(Q53032283)

10 May 2018

title

BRONCHIAL CARCINOMA TREATED WITH NITROGEN MUSTARD AND CYCLOPHOSPHAMIDE. (English)

1 reference

10 May 2018

author name string

BARRAN KM

series ordinal

1

1 reference

10 May 2018

HELM WH

series ordinal

2

1 reference

10 May 2018

KING DA

series ordinal

3

1 reference

10 May 2018

language of work or name

English

0 references

publication date

1 September 1965

1 reference

10 May 2018

number of pages

3

1 reference

inferred from page(s)

published in

The BMJ

1 reference

10 May 2018

volume

2

1 reference

10 May 2018

page(s)

685-687

1 reference

10 May 2018

issue

5463

1 reference

10 May 2018

Nitrogen mustard in treatment of advanced carcinoma of lung; analysis of one hundred ninety-eight cases

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1846100

Conservatism in surgical treatment of bronchial carcinoma. A review of 826 personal operations.

22 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1846100

The response of various types of bronchogenic carcinoma to nitrogen mustard

13 August 2018

1 reference

12 December 2020

Nitrogen mustard in the palliation of lung cancer

1 reference

12 December 2020

Treatment of bronchogenic carcinoma with nitrogen mustard

1 reference

12 December 2020

CYTOTOXIC DRUGS IN BRONCHIAL CARCINOMA

1 reference

12 December 2020

A comparative study of the effectiveness of HN2 and cyclophosphamide in bronchogenic carcinoma, Hodgkin's disease and lymphosarcoma

1 reference

12 December 2020

Cyclophosphamide. An evaluation of its cytostatic effects on surgically treated carcinoma of the lung

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.2.5463.685

1 reference

10 May 2018

PMCID

1846100

1 reference

10 May 2018

PubMed ID

14337737

1 reference

10 May 2018